MAY 25, 2023
Biophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conference Biophytis announces that it presented the positive results of the phase 2-3 COVA study with Sarconeos (BIO101) in severe COVID-19 at the American Thoracic Society International Conference (ATS 2023) that was held in Washington DC between the 19th and…